Dir/Sr. Dir, Program Management Lead at SAGIMET BIOSCIENCES INC.

San Mateo, California, United States -

Full Time

Start Date

Immediate

Expiry Date

20 Aug, 26

Salary

300000.0

Posted On

22 May, 26

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Program Management, Drug Development, Clinical Development, Regulatory Approval, Strategic Planning, Risk Mitigation, Budget Management, Cross-functional Leadership, NDA Submission, Project Management Software, Interpersonal Communication, Small Molecule Development

Industry

Pharmaceutical Manufacturing

Description

Description Position Summary: The R&D Program Management Lead (Director/Sr. Director) will oversee the successful implementation of Sagimet’s research and development programs and translate organizational strategy into actionable program roadmaps and deliverables. This role requires in-depth drug development knowledge to establish, co-ordinate and implement firm timelines and to identify risks, inter-dependencies, and mitigation strategies across functions and programs. The ideal candidate will have experience in taking a small molecule drug candidate through clinical development to regulatory approval, have excellent communication and interpersonal skills and a focus on cross-functional interactions and efficiency. The strong preference is for a candidate located in the San Francisco Bay Area although others will be considered. Key Responsibilities: Collaborate with project leaders to develop and implement strategic plans Collaborate with regulatory to manage NDA timeline Engage in strategic planning in partnership with program leaders to progress clinical stage FASN inhibitors though development. Establish and maintain integrated project timelines for R&D programs, aligning them with the company's overall objectives. Plan and lead development team meetings. Provide regular updates on development program status. Serve as the primary point of contact for stakeholders, including internal staff, consultants and contractors, across functional areas. Identify potential risks and develop mitigation strategies to ensure program success. Develop and manage program budgets, ensuring adherence to financial targets Promote a culture of innovation, encouraging the exploration of new technologies and methodologies to enhance R&D capabilities and performance. Support projects and meetings with external audiences including regulatory authorities, advisory boards and collaborators. Oversee and mentor junior team members as appropriate Collaborate with team members where needed to support scientific review of contracts, management of vendors, and document management. Other duties as assigned. Education and Experience: Bachelor's degree in a relevant field (e.g., Biotechnology, Life Sciences, Engineering, Business Administration). Advanced degree (Master's or Ph.D.) preferred. Minimum of 10 years of experience in clinical stage R&D program management or a related field within the biotech industry. Experience in program managing one or more Phase 3 programs through NDA submission and regulatory approval is a must. Proven track record of managing complex cross-functional projects, ideally experience in small molecule drug development from pre-IND to regulatory approval stage Skills: Exceptional communication, interpersonal and team management skills. Excellent project management and organizational abilities. Familiarity with regulatory requirements and compliance standards for small molecule drug development Proficiency in project management software and tools. Ability to think strategically and drive innovation. Strong problem-solving capabilities, high attention to detail and high-quality work Salary Range: Director = $210,000 - $260,000 Sr. Director = $260,000-$300,000 Actual compensation within this range will be based on the experience and qualifications of the selected candidate.

Responsibilities

Oversee the implementation of R&D programs by translating organizational strategy into actionable roadmaps and deliverables. Lead cross-functional teams to manage timelines, budgets, and risks for clinical stage FASN inhibitors through regulatory approval.